Swiss National Bank increased its holdings in shares of Teladoc Inc (NYSE:TDOC) by 56.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 92,800 shares of the health services provider’s stock after purchasing an additional 33,300 shares during the period. Swiss National Bank owned 0.16% of Teladoc worth $3,234,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also made changes to their positions in TDOC. Bank of New York Mellon Corp lifted its position in shares of Teladoc by 2.3% during the third quarter. Bank of New York Mellon Corp now owns 285,788 shares of the health services provider’s stock worth $9,474,000 after purchasing an additional 6,396 shares during the last quarter. Strs Ohio raised its stake in Teladoc by 33.3% during the fourth quarter. Strs Ohio now owns 304,226 shares of the health services provider’s stock worth $10,602,000 after acquiring an additional 76,057 shares during the period. JPMorgan Chase & Co. raised its stake in Teladoc by 24.4% during the third quarter. JPMorgan Chase & Co. now owns 3,313,729 shares of the health services provider’s stock worth $108,193,000 after acquiring an additional 650,129 shares during the period. New York State Common Retirement Fund raised its stake in Teladoc by 33.2% during the third quarter. New York State Common Retirement Fund now owns 90,513 shares of the health services provider’s stock worth $3,001,000 after acquiring an additional 22,554 shares during the period. Finally, Jennison Associates LLC raised its stake in Teladoc by 130.0% during the third quarter. Jennison Associates LLC now owns 1,793,338 shares of the health services provider’s stock worth $59,449,000 after acquiring an additional 1,013,707 shares during the period.
In other Teladoc news, President Peter A. Mcclennen sold 27,533 shares of the business’s stock in a transaction dated Wednesday, March 7th. The shares were sold at an average price of $43.01, for a total value of $1,184,194.33. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Andrew Turitz sold 36,210 shares of the business’s stock in a transaction dated Tuesday, March 6th. The stock was sold at an average price of $40.39, for a total transaction of $1,462,521.90. Following the completion of the transaction, the senior vice president now directly owns 16,700 shares of the company’s stock, valued at $674,513. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 324,494 shares of company stock worth $12,935,147. Company insiders own 4.47% of the company’s stock.
Shares of Teladoc Inc (NYSE TDOC) traded up $0.15 during trading on Wednesday, hitting $42.95. 1,028,778 shares of the stock traded hands, compared to its average volume of 1,183,280. The company has a debt-to-equity ratio of 0.37, a quick ratio of 3.87 and a current ratio of 3.87. Teladoc Inc has a 1-year low of $21.25 and a 1-year high of $44.65. The firm has a market cap of $2,610.00 and a price-to-earnings ratio of -20.77.
Several equities research analysts have commented on the stock. Cantor Fitzgerald restated a “hold” rating and issued a $35.00 price target (up previously from $31.00) on shares of Teladoc in a research note on Tuesday, February 27th. Chardan Capital reiterated a “buy” rating and set a $47.00 price objective (down previously from $48.00) on shares of Teladoc in a research note on Wednesday, February 28th. Canaccord Genuity raised their target price on shares of Teladoc from $43.00 to $45.00 and gave the stock a “buy” rating in a report on Wednesday, February 28th. Deutsche Bank raised their target price on shares of Teladoc to $45.00 and gave the stock a “buy” rating in a report on Friday, March 2nd. Finally, ValuEngine raised shares of Teladoc from a “sell” rating to a “hold” rating in a research note on Friday, February 2nd. One analyst has rated the stock with a sell rating, five have given a hold rating and twelve have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $40.71.
TRADEMARK VIOLATION NOTICE: This article was posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.thelincolnianonline.com/2018/03/14/teladoc-inc-tdoc-stake-lifted-by-swiss-national-bank.html.
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.